Merix Takes Road Less Traveled To Add Shingles Relief To OTC Monograph
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm argues the three active pharmaceutical ingredients in Releev, for symptomatic relief of cold sores, and Shing-Releev, for shingles and chicken pox, are generally recognized as safe and effective, despite the indications not being included in the monographs.
You may also be interested in...
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
Certain Dri Antiperspirant Sweats It Out Against Big Players
With a thicker, “drip-free” reformulation of Certain Dri launching in January 2014, DSE Healthcare Solutions hopes its clinical-strength roll-on antiperspirant will appeal to more consumers with hyperhidrosis as well as those concerned about but not diagnosed with excessive perspiration.